quinacrine has been researched along with Facial Dermatoses in 2 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
Facial Dermatoses: Skin diseases involving the FACE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hughes, JR | 1 |
| Pembroke, AC | 1 |
| von Schmiedeberg, S | 1 |
| Rönnau, AC | 1 |
| Schuppe, HC | 1 |
| Specker, C | 1 |
| Ruzicka, T | 1 |
| Lehmann, P | 1 |
2 other studies available for quinacrine and Facial Dermatoses
| Article | Year |
|---|---|
Cutaneous sarcoid treated with mepacrine.
Topics: Facial Dermatoses; Humans; Male; Middle Aged; Quinacrine; Sarcoidosis | 1994 |
[Combination of antimalarial drugs mepacrine and chloroquine in therapy refractory cutaneous lupus erythematosus].
Topics: Adult; Antimalarials; Chloroquine; Drug Therapy, Combination; Facial Dermatoses; Female; Humans; Lup | 2000 |